Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Breast Neoplasms

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Breast Neoplasms in 2 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Preclinical animal models of breast cancer provide the opportunity to identify chemopreventive drugs with single-agent activity as well as effective multi-modality regimens for primary as well as secondary prevention in high-risk persons."2.66Data-Driven identification of chemopreventive agents for breast cancer ( Güven, DC; Orhan, C; Şahin, K; Uçkun, FM, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Güven, DC1
Orhan, C1
Şahin, K1
Uçkun, FM1
Kim, S1
Choi, JH1
Lim, HI1
Lee, SK1
Kim, WW1
Cho, S1
Kim, JS1
Kim, JH1
Choe, JH1
Nam, SJ1
Lee, JE1
Yang, JH1

Reviews

1 review available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Breast Neoplasms

ArticleYear
Data-Driven identification of chemopreventive agents for breast cancer
    Turkish journal of medical sciences, 2020, 11-03, Volume: 50, Issue:SI-2

    Topics: Amides; Animals; Antineoplastic Agents; Breast Neoplasms; Chemoprevention; Female; Humans; Mammary N

2020

Other Studies

1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Breast Neoplasms

ArticleYear
EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
    Cellular signalling, 2009, Volume: 21, Issue:6

    Topics: Breast Neoplasms; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Re

2009